Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007

NCT04168957 is registered in ClinicalTrials.gov with Athenex, Inc. as lead sponsor.

NCT NCT04168957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04168957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
Lead sponsor
Athenex, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
October 25, 2017
Completion date
November 12, 2020
Enrollment
11 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breastcancer